http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105277699-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-26 |
| filingDate | 2014-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105277699-B |
| titleOfInvention | Application of detection reagent in preparation of drugs for evaluation of clinical tumor patient clinical treatment monitoring |
| abstract | The invention provides an application of a detection reagent in preparation of drugs for evaluation of clinical tumor patient clinical treatment monitoring; the detection reagent includes the components respectively independently existing: (a) a reagent determining the total sulfydryl content in a sample; and (b) a thioredoxin reductase specific inhibition compound. Clinical treatment includes all kinds of clinical chemotherapies, radiation therapies or other clinical treatment schemes. The detection reagent has obvious activity difference on different treatment stages (such as preoperation, intraoperation and postoperation) and clinical effects (CR, PR, SD and PD) of lung cancer, breast cancer, nasopharyngeal carcinoma and cervical carcinoma, and data analysis display has a statistical significance, therefore, the detection reagent determines the tumor treatment effect through TR activity detection and dynamically monitors the process of related diseases, so that the detection reagent provides great guiding significance on different treatment stages of patients and can be used in clinic. |
| priorityDate | 2014-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 71.